Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Custom Antibody Market Size & Share to Surpass $1.2 Billion by 2030 | Vantage Market Research

Published

on

WASHINGTON, July 28, 2023 (GLOBE NEWSWIRE) — As per Vantage Market Research, the Global Custom Antibody Market has been steadily growing over the years due to the rising demand for individualized and focused treatments across many specialties, including immunology, oncology, and infectious diseases. Custom antibodies are extremely useful for research, diagnostics, and therapeutics because of their superior specificity, sensitivity, and adaptability.

According to Vantage Market Research, the global Custom Antibody Market is estimated to be valued at USD 1.2 billion by 2030 and is expected to exhibit a CAGR of 9.75% during the forecast period 2023 to 2030. The global Custom Antibody Market grew to USD 0.61 billion in 2022.

An antibody that is specifically created and produced to target a particular antigen or protein of interest is referred to as a Custom Antibody. It has many uses, including therapeutics, research, and diagnostics. Through the selective detection, isolation, and study of particular molecules in biological samples, custom antibodies help researchers better understand a variety of diseases and accelerate the creation of targeted treatments.

To Get Additional Highlights on Major Revenue-Generating Segments, Request a Custom Antibody Market Sample Report at@ https://www.vantagemarketresearch.com/custom-antibody-market-2201/request-sample

Key Highlights

  • By Type, in 2022, monoclonal antibodies accounted for 50% of the market for custom antibodies and the market’s fastest-growing subsegment is recombinant antibodies. It is anticipated to grow at a CAGR of 11% from 2023 to 2030.
  • By Service, between 2023 and 2030, antibody production and development are anticipated to grow fastest.
  • By Source, in 2022, the mice category dominated the market.
  • By Application, the diagnostics category is expected to grow at the highest CAGR during 2023-2030.
  • North America held a 44% market share for custom antibodies in 2022.

The Custom Antibody market is essential for numerous applications in numerous industries. Custom antibodies are used in the medical field for therapeutic treatments, cancer research, diagnostic tests, and personalized medicine. They assist in the early detection and management of disease by identifying particular proteins, biomarkers, and pathogens. Custom antibodies are used in the agricultural industry to protect crops and check for harmful ingredients in food products. Custom antibodies are also used in the environmental and forensic fields to monitor pollution, conduct forensic analyses, and identify environmental contaminants. Custom antibodies have numerous uses, which highlights their importance for advancing research and diagnostics as well as enhancing human and environmental health.

Factors Affecting the Growth of the Custom Antibody Market

There are several factors that can affect the growth of the Custom Antibody Market Some of these factors include:

  • Chronic diseases are becoming more common: The demand for custom antibodies is being fueled by the increasing prevalence of chronic diseases like cancer, infectious diseases, and autoimmune disorders. Targeted and particular antibodies are rapidly being developed as a result of the need for personalized treatments for these diseases.
  • Technology advancements in antibody production: The production of specialized antibodies has become easier and faster thanks to developments in phage display, recombinant DNA, and hybridoma technology. These technologies allow for the effective creation of antibody libraries that are tailored to particular targets, which expands the market.
  • Growing life sciences research: There is a significant market for custom antibodies as a result of the growing research in fields like genomics, proteomics, and personalized medicine. Specific antibodies are needed by researchers for numerous applications, such as Western blotting, flow cytometry, immunohistochemistry, and drug discovery, which is fueling market expansion.
  • Increasing investments in biotechnology and pharmaceutical firms: As a result of rising investments in the biotechnology and pharmaceutical industries, there is an increasing emphasis on the creation of novel therapeutics and diagnostics. These developments depend heavily on custom antibodies, which raises consumer demand.
  • Growth of contract research organizations (CROs): The number of CROs providing Custom Antibody services has increased, which has significantly boosted market expansion. For researchers and pharmaceutical companies, outsourcing Custom Antibody production to specialized CROs offers affordable and high-quality solutions, driving market expansion.

To Understand How Our Report Can Bring a Difference to Your Business Strategy, Inquire About a Brochure at@ https://www.vantagemarketresearch.com/custom-antibody-market-2201/inquiry-before-buying

Report Scope

Report Attribute Details
Market Value (2022) USD 0.61 Billion
Market Size (2030) USD 1.2 Billion
CAGR (from 2023 to 2030) 9.8 %
North America Revenue Share 44 %
Historic Period 2018 to 2021
Base Year 2022  
Forecast Year 2023 to 2030

Top Trends in Global Custom Antibody Market

Significant trends are influencing the Custom Antibody market globally and are changing the market. One of the most prominent trends is the rise in personalized medicine, which has stimulated the production of custom antibodies. Additionally, the development of antibodies has been transformed by technological advances such as genomics and next-generation sequencing, which provide more precise and effective solutions. Furthermore, a booming market for customized antibody treatments has been produced by the rising prevalence of chronic diseases and the expanding use of targeted therapy.

Regional Analysis

North America dominates the market, and this trend of dominance will continue throughout the projection period. Government organizations that offer grants and support for antibody research and development include the National Institutes of Health (NIH) in the United States and the Canadian Institutes of Health Research (CIHR) in Canada. Government regulations also guarantee the production and distribution of custom antibodies with regard to quality assurance, security, and moral behavior. The development and growth of the Custom Antibody market in North America are greatly influenced by these government initiatives. Additionally, factors like the presence of many key players, well-developed research infrastructure, and increasing R&D investments drive increased demand for Custom Antibody in this region. Additionally, the Custom Antibody market is expanding at the fastest rate in the Asia-Pacific region. The demand for custom antibodies in this region is being fueled by factors like rising research and development expenditures, rising personalized medicine adoption, and expanding biotechnology and pharmaceutical sectors.

Enjoy a Fabulous 50% Discount with Code “JULY50“! Don’t Miss Out on These Incredible Savings@ https://www.vantagemarketresearch.com/buy-now/custom-antibody-market-2201/0

Market Drivers

The prevalence of chronic diseases like cancer and autoimmune disorders is increasing, which is one of the factors driving the global market for custom antibodies. Additionally, the market is expanding due to the rising demand for targeted therapies and personalized medicine. Custom antibodies with improved specificity and sensitivity have also been made possible by improvements in antibody production technologies like recombinant DNA technology and hybridoma technology. Additionally, the market is growing as custom antibodies are being used more frequently in diagnostics, therapeutics, and research.

Market Restraints

The high cost associated with creating and manufacturing customized antibodies is a significant restraint on the Custom Antibody market. The process of creating a Custom Antibody can be time-consuming and costly, and it calls for specialized knowledge, tools, and materials. The cost of customization is further increased by the frequent use of trial-and-error iterations. Many scientists and organizations, especially those with limited funding, are discouraged from purchasing custom antibodies as a result of these factors.

Market Opportunities

The Custom Antibody market has a huge and bright future ahead of it. There is an increasing need for personalized antibodies to target particular diseases and biomarkers as a result of developments in biotechnology and personalized medicine. It is anticipated that the use of machine learning and artificial intelligence in antibody development will streamline the procedure and increase its effectiveness and efficiency. Additionally, the growth of the market is likely to be fueled by an increase in government funding for healthcare-related research and development, which will make it possible to produce highly specialized antibodies for a variety of therapeutic uses. Future Custom Antibody production is expected to rely heavily on automation. The industry will witness the growth of automated technologies for producing, separating, and describing antibodies.

Grow Your Profit Margin with Vantage Market Research – Purchase This Premium Report at: https://www.vantagemarketresearch.com/buy-now/custom-antibody-market-2201/0

Report Segmentation of the Global Custom Antibody Market

Type Analysis
Due to a number of factors, monoclonal antibodies (mAbs) currently rule the Custom Antibody market. First off, mAbs are perfect for a variety of research applications due to their high specificity and binding affinity. Additionally, they are highly sought-after for personalized medicine due to their simplicity in being tailored to target particular antigens. Their dominance is also aided by the vast knowledge and well-established protocols surrounding the production of monoclonal antibodies. Additionally, improvements in hybridoma technology and recombinant DNA techniques have increased the productivity and cost-effectiveness of mAb production, which has increased their market share.

Service Analysis
For a number of reasons, the market for custom antibodies is dominated by the antibody production and development segment. First off, there is a high demand for custom-made antibodies due to the crucial role that antibodies play in biological research, diagnostics, and therapeutic applications. Technology and genetic engineering advancements have also made it possible to produce highly specific antibodies that are specifically designed for different applications. Additionally, the ability to modify antibodies to meet the precise needs of scientists and medical professionals increases their usefulness and potency in a variety of fields, including immunology, oncology, and infectious diseases. These elements play a part in the Antibody Production and Development segment’s dominance of the Custom Antibody market.

Source Analysis
The Custom Antibody market is dominated by mouse segments for a number of reasons. First off, mice are excellent for producing antibodies because they are highly compatible with human immune systems. Second, because of their sophisticated immune systems, mice are more likely to develop custom antibodies because they can produce a wider variety of antibodies. Mice are also more affordable for mass production, which makes them popular with scientists and businesses. Thus, the mice segment dominates the market for custom antibodies due to their compatibility, diverse antibody generation, and affordability.

Application Analysis
The Custom Antibody market is dominated by the diagnostic segment for a number of reasons. First off, the demand for custom antibodies in diagnostic applications has been fueled by the rising prevalence of chronic diseases and the need for reliable diagnostic tools. Second, the creation and use of custom antibodies for disease detection with higher sensitivity and specificity have been made possible by technological advancements and the accessibility of sophisticated diagnostic platforms. The demand for custom antibodies in diagnostics to identify particular biomarkers for disease diagnosis and treatment has also increased as a result of the growing emphasis on personalised medicine and targeted therapies.

End-User Analysis
The Custom Antibody market is dominated by pharmaceutical and biotechnology companies for a variety of factors. First off, they have a wealth of resources and experience in research and development, which allows them to create innovative and high-quality antibodies. Second, their access to cutting-edge technology makes efficient customization and mass production possible. These businesses frequently collaborate with research organisations and academic institutions, which facilitates knowledge exchange and expands their capabilities. In the end, their dominance in the market is due to their capacity to deliver customised solutions that specifically address the needs of researchers and clinicians.

For More Insights on the Historical and Forecast Market Data From 2023 to 2030 – Download a Sample Report at: https://www.vantagemarketresearch.com/custom-antibody-market-2201/request-sample

Competitive Landscape

The market for custom antibodies is experiencing fierce competition as a result of the rising demand for personalized medicine and biotechnology advancements. To gain a competitive edge, major market players are implementing tactics like mergers, acquisitions, and collaborations. For instance, to increase its capabilities in the antibody production market, Thermo Fisher Scientific recently acquired Novasep’s viral vector manufacturing business. Another noteworthy development is Abcam’s collaboration with Visikol to provide full custom multiplexed antibody services, enabling researchers to simultaneously study numerous protein targets. These developments demonstrate the market’s dynamism and the ongoing efforts of businesses to offer distinctive and effective Custom Antibody solutions.

  • Thermo Fisher Scientific Inc. (U.S.)
  • Creative Diagnostics (U.S.)
  • Abcam PLC (UK)
  • Bio-Rad Laboratories Inc. (U.S.)
  • Kaneka Eurogentec S.A. (Belgium)
  • YenZym Antibodies LLC (U.S.)
  • Abmart (China)
  • Labcorp Drug Development (U.S.)
  • LifeSpan BioSciences Inc. (U.S.)
  • GenScript (U.S.)

Buy this Premium Research Report with Discount | Immediate Delivery @ https://www.vantagemarketresearch.com/buy-now/custom-antibody-market-2201/0

Recent Development of the Global Custom Antibody Market

  • On December 22, 2022, Merck KGaA collaborated with Kelun-Biotech to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer.
  • On July 5, 2022, Bio-Techne acquired Namocell to expand its product portfolio, to include gene therapy development and commercialization, cell engineering, cell line development, single-cell genomics, and antibody discovery.

Browse market data Tables and Figures spread through 144 Pages and in-depth TOC on Custom Antibody Market Forecast Report (2023-2030).

Custom Antibody Market Segmentation
By Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
  • Other Types

By Service

  • Antibody Assay Development
  • Antibody Production and Development
  • Antibody Labeling
  • Antibody Fragmentation
  • Antibody Purification and Conjugation
  • Antibody Engineering and Modification
  • Other Services

By Source

  • Mice
  • Rabbits
  • Other Sources

By Application

  • Research
  • Diagnostic
  • Therapeutic
  • Other Applications

By End-user

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Contract Research Organizations
  • Other End-Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Read Full Report with TOC @ https://www.vantagemarketresearch.com/industry-report/custom-antibody-market-2201

Browse More Reports from Vantage Library:       

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies.

Follow Us on: LinkedIn | Twitter | Facebook | YouTube

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 – 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: [email protected]

Website:

https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases

Latest Vantage Market Research Blog

Vantage Market Research All Reports

Blog:

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024

Published

on

more-than-$9-million-awarded-to-high-school-scientists-and-engineers-at-the-regeneron-international-science-and-engineering-fair-2024

Grace Sun, 16, receives $75,000 Top Award for a new kind of organic electrochemical transistor at the world’s largest pre-college science, technology, engineering and math (STEM) competition.
TARRYTOWN, N.Y. and WASHINGTON, May 17, 2024 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Grace Sun, 16, of Lexington, Kentucky, won the $75,000 top award, the George D. Yancopoulos Innovator Award, named in honor of the pioneering drug researcher and Regeneron co-Founder, Board co-Chair, President and Chief Scientific Officer, in the 2024 Regeneron International Science and Engineering Fair (Regeneron ISEF), the world’s largest pre-college science and engineering competition. Other top prizes went to projects in second-order cone programming, microplastics filtration and multi-sensory therapy for dementia.

The top winners were honored during two award ceremonies: the Special Awards on May 16 and the Grand Awards Ceremony on the morning of May 17. In total, over $9 million USD was awarded to the finalists based on their projects’ creativity, innovation and depth of scientific inquiry. The competition featured nearly 2,000 young scientists representing 49 U.S. states and nearly 70 countries, regions and territories across the world.
Grace Sun, 16, of Lexington, Kentucky, won first place and received the $75,000 George D. Yancopoulos Innovator Award for her research on building a better organic electrochemical transistor that she hopes will be used to develop new electronic devices that could help detect and treat serious illnesses like diabetes, epilepsy and organ failure. To overcome the problems that have previously prevented such devices from working effectively inside the body, Grace developed a new way of chemically treating their organic components, which greatly improved their laboratory performance.
Michelle Wei, 17, of San Jose, California, received one of two Regeneron Young Scientist Awards of $50,000 for her research to improve the speed and efficiency of a type of software that is useful in many fields such as machine learning, transportation and financial systems. Michelle’s new approach involved determining a quick approximate solution to the second-order cone programming problem, then splitting the initial cone into smaller cones, which enabled her new algorithm to greatly outperform previous approaches.
Krish Pai, 17, of Del Mar, California, received the second Regeneron Young Scientist Award of $50,000 for his machine-learning research to identify microbial genetic sequences that can be modified to biodegrade plastic. His new software, called Microby, scans databases of microorganisms and determines which ones can be changed genetically to biodegrade plastics. In tests, he identified two microorganisms that can be genetically modified to degrade plastic at a cost he believes would be ten times less than traditional recycling.
 “Congratulations to the Regeneron International Science and Engineering Fair 2024 winners,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News. “I’m truly inspired by the ingenuity and determination shown by these remarkable students. Coming from around the world with diverse backgrounds and academic disciplines, these students have shown that it is possible to come together in unity to tackle some of the toughest challenges facing our world today, and I could not be prouder.”
Regeneron ISEF provides a global stage for the world’s best and brightest young scientists and engineers. Through this competition, Regeneron and the Society are fostering the next generation of STEM leaders who are pioneering solutions to improve our world. Since 2020, Regeneron has provided STEM experiences to approximately 2.4 million students, on track to meet its goal of 2.5 million by 2025.
“The talent, intelligence and potential of this year’s Regeneron ISEF finalists is truly inspiring, and I congratulate each on their remarkable achievements,” said George D. Yancopoulos, M.D., Ph.D., co-Founder, Board co-Chair, President and Chief Scientific Officer of Regeneron. “Science competitions like ISEF were pivotal in shaping my own career and fueling my passion to fight back against disease. I look forward to seeing these students continue to push the boundaries of science and technology to create positive and sustainable change for all humanity.”
Other top honors from the competition include:
Justin Huang and Victoria Ou, both 17, of Woodlands, Texas, received the Gordon E. Moore Award for Positive Outcomes for Future Generations of $50,000 for their new prototype filtration system that uses ultrasonic waves to remove microscopic plastic particles from water. In lab tests, the acoustic force from the high-frequency sound waves removed between 84% and 94% of the suspended microplastic particles in a single pass. The students are now working to scale up and fine-tune their experimental system.
Ingrid Wai Hin Chan, 17, of Hong Kong, China received the Craig R. Barrett Award for Innovation of $10,000 for her research on using a multi-sensory therapy for dementia patients. Her mixed therapy app would allow patients to practice physical and cognitive skills through a personalized, immersive environment using virtual reality headsets. Ingrid conducted an eight-week study with six people living with dementia and found that the cognitive function of patients who used her prototype improved in several areas. She believes her app could serve as a viable option for dementia patients with limited access to in-person professional therapy.
Tanishka Balaji Aglave, 15, of Valrico, Florida, received the H. Robert Horvitz Prize for Fundamental Research of $10,000 for her investigation into a natural alternative treatment against citrus greening, a disease that threatens citrus farming in many parts of the world and is currently only treated with antibiotics. Tanishka injected the trunks of infected trees with an extract from the curry leaf tree, and found through tests that this potential method could effectively and sustainably manage citrus greening disease.
Maddux Alexander Springer, 18, of Honolulu, Hawaii, received the Peggy Scripps Award for Science Communication of $10,000 for his research into fibropapillomatosis (FP), a disease that is the primary cause of death in green sea turtles. Some turtles he studied in Kaneohe Bay, Hawaii, were stricken with a disease that causes internal and external tumors that inhibit their everyday lives. After analyzing the turtles’ diet of green algae, Maddux concluded that this disease, wastewater, invasive algae and the amino acid arginine all pose a grave risk to these endangered sea creatures.
Ria Kamat, 17, of Hackensack, New Jersey; Anna Oliva, 17, of Houston, TX; and Shuhan Luo, 18, of Worcester, MA, received the Dudley R. Herschbach SIYSS Award, which provides finalists an all-expense paid trip to attend the Stockholm International Youth Science Seminar during Nobel Week in Stockholm, Sweden.
Jack Shannon, 18, of Clane, Kildare, Ireland, and Nikhil Vemuri, 17, of Cary, North Carolina, received the EU Contest for Young Scientists Award. Their projects will represent Regeneron ISEF at the EU Contest for Young Scientists to be held this September in Katowice, Poland.
For more information about the top winners and access to visual assets visit:  https://www.societyforscience.org/isef-2024-media-kit.
The full list of Special Award ISEF 2024 Finalists can be found at https://www.societyforscience.org/press-release/regeneron-isef-2024-special-awards-winners.
In addition to the Top Award winners, more than 450 finalists received awards and prizes for their innovative research, including “First Award” winners, who each received a $5,000 prize.
The following lists the First Award winners for each of the 22 categories, from which the Top Awards were chosen:
Animal Sciences, sponsored by Society for ScienceMaddux Alexander Springer, Honolulu, Hawaii
Behavioral and Social Sciences, sponsored by Society for ScienceAndrew Y. Liang, San Jose, California
Biochemistry, sponsored by RegeneronAmy Hong Xiao, Garden City, New York
Biomedical and Health Sciences, sponsored by RegeneronRia Kamat, Hackensack, New Jersey; Kevin Xuan Lei, Shanghai, China
Biomedical Engineering, sponsored by Alfred E. Mann CharitiesAyush Garg, Dublin, California; Divij Motwani, Palo Alto, California; Akash Ashish Pai, Portland, Oregon
Cellular and Molecular Biology, sponsored by RegeneronLara and Maya Sarah Hammoud, Beverly Hills, Michigan
Chemistry, sponsored by Society for ScienceAkilan Sankaran, Albuquerque, New Mexico; Arjun Suresh Malpani and Siddharth Daniel D’costa, Portland, Oregon
Computational Biology and Bioinformatics, sponsored by RegeneronKun-Hyung Roh, Bronx, New York
Earth and Environmental Sciences, sponsored by Google.orgNikhil Vemuri, Durham, North Carolina; Justin Yizhou Huang and Victoria Ou, The Woodlands, Texas
Embedded Systems, sponsored by HPChloe Rae and Sophie Rose Filion, Welland, Ontario, Canada
Energy: Sustainable Materials and Design, sponsored by Siemens EnergyAlia Wahban, Hamilton, Ontario, Canada
Engineering Technology: Statics and Dynamics, sponsored by Howmet Aerospace FoundationChiyo Nakatsuji, Bunkyoku, Tokyo, Japan; Kevin Shen, Olympia, Washington
Environmental Engineering, sponsored by JacobsKrish Pai, San Diego, California; Jack Shannon, Clane, Kildare, Ireland
Materials Science, sponsored by Howmet Aerospace FoundationGrace Sun, Lexington, Kentucky
Mathematics, sponsored by Akamai FoundationAnna Oliva, Houston, Texas
Microbiology, sponsored by Schattner FoundationMatthew Chang, Irvine, California
Physics and Astronomy, sponsored by Richard F. Caris Charitable Trust IIHarini Thiagarajan and Vishal Ranganath Yalla, Bothell, Washington; Shuhan Luo, Worcester, Massachusetts
Plant Sciences, sponsored by Society for SciencePauline Estrada, Fresno, California; Tanishka Balaji Aglave, Dover, Florida
Robotics and Intelligent Machines, sponsored by RegeneronMichal Lajciak, Dubnica nad Vahom, Trenciansky kraj, Slovakia; Anthony Efthimiadis, Oakville, Ontario, Canada
Systems Software, sponsored by MicrosoftMichelle Wei, San Jose, California
Technology Enhances the Arts, sponsored by Society for ScienceAnant Khandelwal, Sritan Motati and Siddhant Sood, Alexandria, Virginia
Translational Medical Science, sponsored by RegeneronZheng-Chi Lee, West Lafayette, Indiana; Ingrid Wai Hin Chan, Hong Kong, China
The full list of all award-winning ISEF 2024 finalists is available here: https://www.societyforscience.org/press-release/regeneron-isef-2024-full-awards.
View all the finalists’ research here: https://projectboard.world/isef.
About the Regeneron International Science and Engineering FairThe Regeneron International Science and Engineering Fair (Regeneron ISEF), a program of Society for Science for over 70 years, is the world’s largest global science competition for high school students. Through a global network of local, regional and national science fairs, millions of students are encouraged to explore their passion for scientific inquiry. Each spring, a group of these students is selected as finalists and offered the opportunity to compete for approximately U.S. $9 million in awards and scholarships.
In 2019, Regeneron became the title sponsor of ISEF to help reward and celebrate the best and brightest young minds globally and encourage them to pursue careers in STEM to positively impact the world. Regeneron ISEF is supported by a community of additional sponsors, including Akamai Foundation, Alfred E. Mann Charities, Aramco, Caltech, Google.org, Gordon and Betty Moore Foundation, Howmet Aerospace Foundation, HP, , Jacobs, King Abdulaziz & his Companions Foundation for Giftedness and Creativity, Microsoft, National Geographic Society, Richard F. Caris Charitable Trust II, Rise, an initiative of Schmidt Futures and the Rhodes Trust, Schattner Foundation, Siemens Energy, Annenburg Foundation, Ballmer Group, Broadcom Foundation, Cesco Linguistic Services, Conrad N. Hilton Foundation, Edison International, Insaco, Oracle Academy, The Eli and Edythe Broad Foundation, The Ralph M. Parsons Foundation and US Army ROTC. Many are entrepreneurs across a wide range of industries. Learn more at https://www.societyforscience.org/isef/.
About Society for ScienceSociety for Science is a champion for science, dedicated to promoting the understanding and appreciation of science and the vital role it plays in human advancement. Established in 1921, Society for Science is best known for its award-winning journalism through Science News and Science News Explores, its world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair and the Thermo Fisher Scientific Junior Innovators Challenge, and its outreach and equity programming that seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate and inspire. Learn more at www.societyforscience.org and follow us on Facebook, Twitter, Instagram and Snapchat (Society4Science).
About RegeneronRegeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases. 
Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture of integrity and excellence and to build sustainable communities. Regeneron is proud to be included on the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the U.S. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro bono and matching gift programs. Our most significant philanthropic commitments are in the area of early science education, including the Regeneron Science Talent Search and the Regeneron International Science and Engineering Fair (ISEF).
For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.
More information about the top winners and access to visual assets visit:  https://www.societyforscience.org/isef-2024-media-kit.
Media ContactsJoseph Brown, [email protected]
Gayle Kansagor, Society for [email protected]
Photo – https://mma.prnewswire.com/media/2416174/Regeneron_ISEF_2024_Winners_Photo.jpg 
Logo – https://mma.prnewswire.com/media/2416197/Society_for_Science_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/more-than-9-million-awarded-to-high-school-scientists-and-engineers-at-the-regeneron-international-science-and-engineering-fair-2024-302149316.html

Continue Reading

Artificial Intelligence

J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Announce Winner of Inaugural 2024 Life Sciences Innovation Summit

Published

on

jp.-morgan-life-sciences-private-capital,-blue-horizon-advisors-and-united-al-saqer-announce-winner-of-inaugural-2024-life-sciences-innovation-summit

In conjunction with Abu Dhabi Global Healthcare Week 2024
ABU DHABI, UAE, May 17, 2024 /PRNewswire/ — J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Group announced today Rayees Rahman of Harmonic Discovery as the winner of the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit. Harmonic Discovery is a precision pharmacology company applying its generative chemistry platform to advance next-generation kinase inhibitors.

In partnership with the Department of Health – Abu Dhabi (DoH), the Summit took place on May 14-15, 2024 at Cleveland Clinic Abu Dhabi and showcased the 11 innovative finalists, as well as highlighted existing innovators and opportunities in the Emirate of Abu Dhabi. The event also featured keynote speeches from Dr. Laurie Glimcher of Dana-Farber Cancer Institute, Dr. Shahrukh Hashmi of the Department of Health – Abu Dhabi, and Dr. David Ho of Columbia University Medical Center and provided attendees networking opportunities to gain valuable insights into the future of life sciences innovation. 
In addition, the jury designated Chun-Hao Huang of Algen Biotechnologies as honourable mention. Algen Biotechnologies is a platform therapeutics and drug discovery company using world-leading CRISPR and AI to find treatments for cancer, inflammation and metabolic diseases.
The winners were selected by an esteemed, international panel of judges, which included:Laurie Glimcher, MD, President and CEO at Dana-Farber Cancer InstituteJorge Guzman, MD, CEO at Cleveland Clinic Abu DhabiProf. Shahrukh Khurshid Hashmi, MD, Director of Research, Department of Health, Abu DhabiYasmine Hayek Kobeissi, PhD, CQF, BSc., Executive Director at Blue Horizon AdvisorsAnya Schiess, Managing Partner at J.P. Morgan Life Sciences Private CapitalWalid Zaher, PhD, Co-Founder and CEO, Carexso
Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Centre at the Department of Health – Abu Dhabi said: “Under the directives of the UAE’s wise leadership, and renowned for its world-leading medical infrastructure, Abu Dhabi stands at the forefront of healthcare excellence, offering an unparalleled opportunity for advancement in healthcare for global partners. It was our utmost pleasure hosting the J.P. Morgan Asset Management Life Sciences Innovation Summit 2024 on the sidelines of Abu Dhabi Global Healthcare Week and we commend the winners for their pioneering efforts in driving impactful advancements in healthcare; their dedication to innovation not only transforms the landscape of medicine, but also holds the promise of improving lives worldwide.” 
Stephen Squinto, PhD, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital said: “We are thrilled with the level of biotech passion and innovation that we observed at this year’s Summit in Abu Dhabi. The energy was truly palpable we are thrilled to announce Rayees Rahman as the winner of our first Life Sciences Innovation Summit. Harmonic Discovery’s approach embodies the next generation of drug discovery and development. We appreciate the time and effort of all participants and cannot wait for our next event in the region.”
Nabil Kobeissi, Chief Executive Officer of Blue Horizon Advisors, said: “As the main sponsor, we are committed to nurturing and fostering the growth of all 11 finalists in this vibrant biotech ecosystem. This Summit marks the beginning of a transformative journey, and we are confident that it will pave the way for a flourishing hub in the region. We are also pleased to announce that we will commit to invest in and partner with the winner, Harmonic Discovery, to support its future growth in the region.”
Sponsors for the event included J.P. Morgan Life Sciences Private Capital, J.P. Morgan Commercial Bank, Blue Horizon Advisors, United Al Saqer Group, Thermo Fisher Scientific, and Salam Capital. The Summit organisation, logistics and finalist recruitment were facilitated by Lyfebulb.
Of importance, at the Summit, Mr. Mohamed Al Breiki, Executive Director of Sustainable Development at Masdar City, announced that Masdar City Free Zone would award all 11 Finalists complimentary business licenses to further support their establishment in the region. Masdar City is one of the world’s most sustainable urban developments and innovation hubs with a growing focus on life science entrepreneurship in Abu Dhabi.

View original content:https://www.prnewswire.co.uk/news-releases/jp-morgan-life-sciences-private-capital-blue-horizon-advisors-and-united-al-saqer-announce-winner-of-inaugural-2024-life-sciences-innovation-summit-302149186.html

Continue Reading

Artificial Intelligence

Congregating in the Lion City for a Win-Win Future of Intelligent Computing at the Global Data Center Facility Summit 2024

Published

on

congregating-in-the-lion-city-for-a-win-win-future-of-intelligent-computing-at-the-global-data-center-facility-summit-2024

SINGAPORE, May 17, 2024 /PRNewswire/ — On May 17, 2024, the Global Data Center Facility Summit 2024 was held in Singapore with the theme of “Power the Digital Era Forward.” At the summit, over 600 data center industry leaders, technical experts, and ecosystem partners gathered to discuss new trends and opportunities of the global data center industry in the intelligent computing era. The attendees also got to experience all-scenario, all-ecosystem, and all-service end-to-end (E2E) solutions, share innovative practices of green data centers in the Asia Pacific and Europe, and experience the exhibition vehicle to unveil the mystery of Outdoor PowerPOD that features one power system per container. By fully embracing the intelligent computing era, Huawei strives to power the digital era forward.

Seizing Opportunities Brought by AI and Jointly Building Green & Reliable Computing Infrastructure
At the opening speech, Charles Yang, Senior Vice President of Huawei and President of Marketing, Sales and Services, Huawei Digital Power, noted that since ChatGPT ushered in the AI era, large models keep pushing the limits of computing power and the intelligent computing industry is witnessing an unprecedented construction boom. As predicted, 100 GW will be added to the global data center installed capacity and the market value will exceed US$600 billion in the next five years.
According to Charles, with opportunities come challenges. The primary challenge concerning the data center industry is reliability and electricity. Data centers are scaling up from the MW-level to the GW-level. E2E reliability of data centers is becoming even more important than ever. In response to the opportunities, Huawei will work with customers and partners to expand the industry space.
Steering Data Centers to the AI Era with Product + Service + Ecosystem
During the summit, Sun Xiaofeng, President of Huawei Data Center Facility & Critical Power Business, delivered a speech titled “Power the Digital Era Forward. ” He stated that as AI large models are penetrating, the surging compute demands drive the expansive growth in data center.
To address the challenges, Huawei strives to build product + service + ecosystem E2E data center solutions that feature fast deployment, flexible cooling, green energy, and ultimate reliability.
Fast deployment: Data centers are fully modularized and prefabricated to ensure high quality and efficient construction.Flexible cooling: Air-liquid fusion and integrated cooling source emerges as the optimal cooling architecture for intelligent computing.Green energy: New generation-grid-load-storage integrated solution is built to ensure the sound operations of intelligent computing centers.Ultimate reliability: Data centers are safeguarded through reliable products and preventive protection.Currently, Huawei’s global service network covers more than 170 countries with over 1800 professional engineers, providing 24/7 technical support. With N+ flagship service centers, Huawei has built a one-hour service radius for its customers.
The ecosystem is a key part for a win-win future of intelligent computing. Huawei works with partners to develop comprehensive E2E solutions and provide customers with one-stop data center services.
During the summit, Huawei and the ASEAN Centre for Energy released a white paper on “Building Next Generation Data Center Facility in ASEAN.” The document provides insights into the status quo, challenges, and trends of data centers in the ASEAN region, and emphasizes that efficient and energy-saving products and solutions should be applied. It also proposes future-oriented policy recommendations for data center markets.
In the ecosystem exhibition area, Huawei showcased scenario-based solutions for large-, medium-, and small-sized data centers, and demonstrated data center consulting, design, integrated development, and delivery capabilities with dozens of ecosystem partners including CIMC, Weichai, CSCEC, and Huashi.
On a special note, the Huawei Outdoor PowerPOD exhibition vehicle made its global debut. The Huawei Outdoor PowerPOD features one power system per container, outdoor deployment, plug-and-play, and high protection rating and reliability. It has become the preferred choice for decoupling the power supply architecture.
A single tree cannot make a forest.
AI is presenting great opportunities. By delving into the industry, aggregating partner ecosystems, and making innovations applicable to transformations, Huawei will continue to help customers build reliable computing infrastructure, accelerating the industry to embrace AI and powering the digital era forward.
Photo – https://mma.prnewswire.com/media/2415818/Global_Data_Center_Facility_Summit_2024.jpg

View original content:https://www.prnewswire.co.uk/news-releases/congregating-in-the-lion-city-for-a-win-win-future-of-intelligent-computing-at-the-global-data-center-facility-summit-2024-302148973.html

Continue Reading

Trending